Can negligible hepatic steatosis determined by magnetic resonance imaging–proton density fat fraction obviate the need for liver biopsy in potential liver donors?

Liver Transplantation

Volumn 24, Issue 4, 2018, Pages 470-477

  Satkunasingham, Janakan ^a   Nik, Hooman Hosseini ^a   Fischer, Sandra ^b   Menezes, Ravi ^a   Selzner, Nazia ^c   Cattral, Mark ^c   Grant, David ^c   Jhaveri, Kartik ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FEMALE; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; MAGNETIC RESONANCE PROTON DENSITY FAT FRACTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGAN DONOR; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ALLOGRAFT; BIOPSY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DONOR SELECTION; EVALUATION STUDY; IMAGE PROCESSING; LIVER; LIVER TRANSPLANTATION; LIVING DONOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; STANDARD; YOUNG ADULT;

ADULT; ALLOGRAFTS; BIOPSY; DONOR SELECTION; FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85044463269     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24965     Document Type: Article

References (40)

1. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105-113.
2. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239-244.
3. Perez-Daga JA, Santoyo J, Suárez MA, Fernández-Aguilar JA, Ramírez C, Rodríguez-Cañete A, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 2006;38:2468-2470.
4. Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T. Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 2009;96:437-444.
5. Shin YH, Ko JS, Kim GS, Gwak MS, Sim WS, Lee AR, et al. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors. Transplant Proc 2012;44:512-515.
6. Sharma A, Ashworth A, Behnke M, Cotterell A, Posner M, Fisher RA. Donor selection for adult-to-adult living donor liver transplantation: well begun is half done. Transplantation 2013;95:501-506.
7. Trotter JF, Campsen J, Bak T, Wachs M, Forman L, Everson G, Kam I. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant 2006;6:1882-1889.
8. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, et al. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging 2015;40:795-802.
9. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings. Radiology 2006;240:116-129.
10. Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348:818-825.
11. Nadalin S, Malagó M, Valentin-Gamazo C, Testa G, Baba HA, Liu C, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl 2005;11:980-986.
12. Brandhagen D, Fidler J, Rosen C. Evaluation of the donor liver for living donor liver transplantation. Liver Transpl 2003;9(suppl 2):S16-S28.
13. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-1122.
14. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
15. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al.; for LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-1906.
16. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250:691-697.
17. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729-749.
18. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011;21:87-97.
19. Roldan-Valadez E, Favila R, Martínez-López M, Uribe M, Ríos C, Méndez-Sánchez N. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: correlation with biochemical method and morphometry. J Hepatol 2010;53:732-737.
20. van Werven JR, Schreuder TC, Aarts EO, Nederveen AJ, Meijer JW, Berends FJ, et al. Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery: assessment with open-system 1H-MR spectroscopy. AJR Am J Roentgenol 2011;196:W736-W742.
21. Hájek M, Dezortová M, Wagnerová D, Skoch A, Voska L, Hejlová I, Trunečka P. MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients. MAGMA 2011;24:297-304.
22. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
23. Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 2007;242:450-455.
24. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60:1122-1134.
25. Kinner S, Reeder SB, Yokoo T. Quantitative imaging biomarkers of NAFLD. Dig Dis Sci 2016;61:1337-1347.
26. Satkunasingham J, Besa C, Bane O, Shah A, de Oliveira A, Gilson WD, et al. Liver fat quantification: comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy. Eur J Radiol 2015;84:1452-1458.
27. Jhaveri KS, Guo L, Guimarães L. Current state-of-the-art MRI for comprehensive evaluation of potential living liver donors. AJR Am J Roentgenol 2017;209:55-66.
28. Hwang I, Lee JM, Lee KB, Yoon JH, Kiefer B, Han JK, Choi BI. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology 2014;271:730-738.
29. Joe E, Lee JM, Kim KW, Lee KB, Kim SJ, Baek JH, et al. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI. J Magn Reson Imaging 2012;36:1124-1130.
30. Yoon JH, Lee JM, Suh KS, Lee KW, Yi NJ, Lee KB, et al. Combined use of MR fat quantification and MR elastography in living liver donors: can it reduce the need for preoperative liver biopsy? Radiology 2015;276:453-464.
31. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003;9:851-856.
32. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
33. Chiang HJ, Lin LH, Li CW, Lin CC, Chiang HW, Huang TL, et al. Magnetic resonance fat quantification in living donor liver transplantation. Transplant Proc 2014;46:666-668.
34. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010;256:159-168.
35. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431.
36. Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010;52:579-585.
37. Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012;47:368-375.
38. Kühn JP, Hernando D, Muñoz del Rio A, Evert M, Kannengiesser S, Völzke H, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265:133-142.
39. Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imag Clin N Am 2010;18:337-357.
40. Artz NS, Haufe WM, Hooker CA, Hamilton G, Wolfson T, Campos GM, et al. Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imaging 2015;42:811-817.